<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" 
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
  <url>
    <loc>https://www.openbell.ai/</loc>
    <lastmod>2026-10-06T20:37:51.943Z</lastmod>
    <changefreq>hourly</changefreq>
    <priority>1.0</priority>
  </url>
  <url>
    <loc>https://www.openbell.ai/support</loc>
    <lastmod>2026-10-06T20:37:51.943Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://www.openbell.ai/privacy</loc>
    <lastmod>2026-10-06T20:37:51.943Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.openbell.ai/terms</loc>
    <lastmod>2026-10-06T20:37:51.943Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.openbell.ai/feed.json</loc>
    <lastmod>2026-10-06T20:37:51.943Z</lastmod>
    <changefreq>hourly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/AXIL:1791319057890</loc>
    <lastmod>2026-10-06T20:37:37.890Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/AXIL/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>AXIL Brands shares are trading lower after the company reported worse-than-expected Q1 financial results.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/CRBU:1791319024372</loc>
    <lastmod>2026-10-06T20:37:04.372Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/CRBU/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Caribou Biosciences shares are trading lower after the company announced it is exploring strategic alternatives.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/AMTD:1791318772247</loc>
    <lastmod>2026-10-06T20:32:52.247Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/AMTD/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>AMTD IDEA Group Announces ADS Ratio Change To One ADS Per 360 Class A Ordinary Shares, Effective October 19, Equivalent To One-For-60 Reverse Split</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/BMRN:1791318712216</loc>
    <lastmod>2026-10-06T20:31:52.216Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/BMRN/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>BioMarin Pharmaceutical Expects Q3 Pre-Tax Charges Of $283M For Bought IPR&amp;amp;d Expense; Expects $1.5 Unfavorable Impact To GAAP And Non-gaap Diluted EPS For Q3; Expects Total Pre-Tax Charges Of $320M For FY26 From Alesta Acquisition; Expects $1.55 Unfavorable Impact To GAAP And Non-Gaap Diluted EPS For FY26</image:title>
      <image:caption>BioMarin Pharmaceutical anticipates pre-tax charges of $283 million for Q3 due to acquired IPR&amp;D expenses, which will negatively impact GAAP and non-GAAP diluted EPS by $1.5. For the fiscal year 2026, the company expects total pre-tax charges of $320 million related to the Alesta acquisition, leading to a projected unfavorable impact of $1.55 on GAAP and non-GAAP diluted EPS.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/BLCO:1791318704625</loc>
    <lastmod>2026-10-06T20:31:44.625Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/BLCO/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Bausch + Lomb Says FDA Supportive In Principle Of Initial Study Design For Oral Dry AMD Drug BL1243, Expects 2027 Start</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/PENG:1791318521536</loc>
    <lastmod>2026-10-06T20:28:41.536Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/PENG/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>CORRECTION: Penguin Solutions Sees FY2027 Adj EPS $3.75-$5.15 vs $3.25 Est; Sees Sales $2.250B-$2.596B vs $2.201B Est</image:title>
      <image:caption>Penguin Solutions (NASDAQ: PENG) has projected its FY2027 adjusted earnings per share (EPS) to be between $3.75 and $5.15, exceeding the analyst estimate of $3.25. The company anticipates sales in the range of $2.250 billion to $2.596 billion, also above the analyst estimate of $2.201 billion.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/BKNG:1791318353976</loc>
    <lastmod>2026-10-06T20:25:53.976Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/06/Benzinga-Quick-Spark.jpg?width=250&amp;height=187</image:loc>
      <image:title>QUICK SPARK: Booking Holdings Stock Eyes 9th Straight Week of Losses, Worst Streak Ever</image:title>
      <image:caption>Booking Holdings Inc. (NASDAQ: BKNG) is experiencing its longest losing streak since its IPO, with the stock down for eight consecutive weeks and currently priced at $157.36, a 1.04% decline this week. Since August 7, shares have dropped 26.6% and are 31.6% below their all-time high of $230.13 set on July 7, 2025. Factors contributing to this decline include the EU General Court&#39;s decision to block the eTraveli deal, rising airfare concerns due to Brent oil prices above $100, and investor fears regarding the impact of AI booking agents on commission rates for online travel agencies.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/CAR:1791318301463</loc>
    <lastmod>2026-10-06T20:25:01.463Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/CAR/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Avis Budget Group Was Paid $650M Cash Settlement On October 5, 2026;  Settlement Payment Approved By Court To Be Recognized In Q4 Financials; Settlement With Pentwater Capital Management LP Resolves Short-Swing Profits Lawsuit</image:title>
      <image:caption>On October 5, 2026, Avis Budget Group, Inc. received a $650 million cash settlement from Pentwater Capital Management LP, resolving a lawsuit regarding short-swing profits under Section 16(b) of the Securities Exchange Act of 1934. The court-approved settlement will be reflected in the company&#39;s Q4 financial statements. Avis plans to allocate part of the settlement to repay $350 million of its 5.750% Senior Notes due 2027.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/SRXH:1791318191234</loc>
    <lastmod>2026-10-06T20:23:11.234Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/SRXH/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>SRX Global Announces $1.5M Commitment To Roll Out New Family Of Actively Managed ETFs</image:title>
      <image:caption>SRX Global Inc. (NYSE American: SRXH) has announced a $1.5 million commitment to launch a new family of actively managed Exchange Traded Funds (ETFs) via its EMJX platform. This initiative aims to leverage EMJX’s proprietary AI-driven investment intelligence for the broader investing public, reflecting the company&#39;s focus on generating long-term shareholder value.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/FCEL:1791318015847</loc>
    <lastmod>2026-10-06T20:20:15.847Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/06/The-Fuelcell-Energy--Inc--Logo-Is-Displa.jpg?width=250&amp;height=187</image:loc>
      <image:title>FuelCell Energy Stock Gains 14% Today — Here&amp;#39;s Why</image:title>
      <image:caption>FuelCell Energy Inc. (NASDAQ: FCEL) saw its stock rise by 14.28% to close at $20.65 following a significant 20-year power purchase agreement between Alphabet Inc. and Constellation Energy Corp. to add 890 megawatts of nuclear capacity. This deal, which involves over $4.3 billion in upgrades to existing reactors, indicates sustained demand for power in data centers. Additionally, approximately 31.19% of FuelCell&#39;s shares were sold short, contributing to stock volatility and potential price increases as short sellers may be forced to cover their positions.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/ZETA:1791318006484</loc>
    <lastmod>2026-10-06T20:20:06.484Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/ZETA/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Zeta Global Agrees To Acquire Digital Audience; Financial Terms Not Disclosed</image:title>
      <image:caption>Zeta Global (NYSE: ZETA) has announced an agreement to acquire Digital Audience, a company specializing in data infrastructure that enhances identity and activation capabilities in the digital ecosystem. The financial terms of the acquisition have not been disclosed.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/VOYA:1791317966367</loc>
    <lastmod>2026-10-06T20:19:26.367Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/VOYA/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Voya Financial Expects Q3 Alternative Investment Income Of $40M -$50M Pre-Tax; Mid-Point Of Q3 Alternative Investment Income Range Represents 8.5% Annualized Return</image:title>
      <image:caption>Voya Financial anticipates its alternative investment income for Q3 to be between $40 million and $50 million pre-tax, with the midpoint indicating an annualized return of 8.5%. This projection reflects the company&#39;s ongoing focus on alternative investments as a significant revenue stream.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/FTI:1791317889667</loc>
    <lastmod>2026-10-06T20:18:09.667Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/FTI/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>TechnipFMC Awarded Subsea Contract By Petrobras To Supply Flexible Pipe Systems Supporting Developments Offshore Brazil</image:title>
      <image:caption>TechnipFMC (NYSE: FTI) has secured a subsea contract from Petrobras to supply flexible pipe systems for offshore developments in Brazil. The contract involves the design, engineering, and manufacturing of flexible flowlines for multiple pre-salt fields, utilizing local resources to enhance Brazil&#39;s offshore energy sector.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/PENG:1791317867399</loc>
    <lastmod>2026-10-06T20:17:47.399Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/PENG/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Penguin Solutions shares are trading higher after the company reported better-than-expected Q4 financial results and issued FY27 EPS guidance above estimates. The company appointed Stephen Cumming as CFO.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/AXIL:1791317860770</loc>
    <lastmod>2026-10-06T20:17:40.770Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/AXIL/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>AXIL Brands Q1 EPS $0.05 Misses $0.13 Estimate, Sales $6.090M Miss $8.118M Estimate</image:title>
      <image:caption>AXIL Brands reported Q1 earnings of $0.05 per share, missing the analyst estimate of $0.13 by 61.54%. This represents a 25% increase from $0.04 per share in the same quarter last year. The company&#39;s sales were $6.090 million, falling short of the $8.118 million estimate by 24.98%, and reflecting an 11.17% decrease from $6.856 million in the prior year.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/NEOG:1791317798549</loc>
    <lastmod>2026-10-06T20:16:38.549Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/NEOG/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Neogen shares are trading higher after the company reported better-than-expected Q1 financial results and raised its FY27 sales guidance.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/STZ:1791317790294</loc>
    <lastmod>2026-10-06T20:16:30.294Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/STZ/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Constellation Brands Acquires SpikedAde For $75M</image:title>
      <image:caption>Constellation Brands, Inc. (NYSE: STZ) has acquired SpikedAde for $75 million, gaining 100% ownership of the brand, which operates in the sports drink-inspired RTD beverage segment. The deal includes potential additional payments of up to $278 million over five years, contingent on SpikedAde&#39;s future performance, highlighting Constellation&#39;s strategic capital allocation approach.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/LSCC:1791317783613</loc>
    <lastmod>2026-10-06T20:16:23.613Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/LSCC/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>William Blair Initiates Coverage On Lattice Semiconductor with Outperform Rating</image:title>
      <image:caption>William Blair analyst Sebastien Naji has initiated coverage on Lattice Semiconductor (NASDAQ: LSCC) with an Outperform rating. This marks a positive outlook for the company in the market.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/NPB:1791317762140</loc>
    <lastmod>2026-10-06T20:16:02.140Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/NPB/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Northpointe Bancshares Raises Quarterly Dividend From $0.025 To $0.03/Share</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/BKH:1791317701012</loc>
    <lastmod>2026-10-06T20:15:01.012Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/BKH/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Black Hills Signs Definitive Agreements Effective Sept. 30, 2026, With Terms Through 2048, To Serve A Planned Google Data Center To Be Constructed In Cheyenne, Wyoming; Investing $1.8B In New Company-Owned Natural Gas Generation; Project Is Expected To Deliver ~$2.4B Of Unlevered Free Cash Flow, Net Of $1.8B Of Generation Capital Investment</image:title>
      <image:caption>Black Hills Corp. has signed definitive agreements effective September 30, 2026, to provide energy services for a planned Google data center in Cheyenne, Wyoming, with terms extending through 2048. The company will invest $1.8 billion in new natural gas generation to support the project, which is expected to generate approximately $2.4 billion of unlevered free cash flow, net of the capital investment. The project will deliver up to 590 megawatts of energy service and is anticipated to contribute around $150 million in net income by 2030.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/RVTY:1791317670397</loc>
    <lastmod>2026-10-06T20:14:30.397Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/RVTY/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>William Blair Initiates Coverage On Revvity with Outperform Rating</image:title>
      <image:caption>William Blair analyst Matt Larew has initiated coverage on Revvity (NYSE: RVTY) with an Outperform rating. This marks a positive outlook for the company as it begins to attract analyst attention.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/RCKT:1791317599418</loc>
    <lastmod>2026-10-06T20:13:19.418Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/RCKT/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Rocket Pharmaceuticals Announces Up To $150M Credit Facility With Hercules Capital, $35M Received At Closing; Expects Cash Runway Into Q3 2028</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/WS:1791317598040</loc>
    <lastmod>2026-10-06T20:13:18.040Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/WS/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Worthington Steel Q1 Adj. EPS $0.57 Misses $0.68 Estimate, Sales $2.727B Beat $885.900M Estimate</image:title>
      <image:caption>Worthington Steel reported Q1 adjusted earnings per share of $0.57, missing the analyst estimate of $0.68 by 16.18%, and reflecting a 25.97% decrease from $0.77 in the same period last year. However, the company&#39;s sales reached $2.727 billion, surpassing the consensus estimate of $885.900 million by 207.82% and marking a 212.41% increase from $872.900 million in the previous year.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/BY:1791317513184</loc>
    <lastmod>2026-10-06T20:11:53.184Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/BY/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Byline Bancorp Announces $87.9M Cash-And-Stock Deal To Acquire Illinois State Bancorp; Expects Close In Q1 2027</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/PENG:1791317486951</loc>
    <lastmod>2026-10-06T20:11:26.951Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/PENG/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Penguin Solutions Sees FY2027 GAAP EPS $2.80-$4.20 vs $2.13 Est</image:title>
      <image:caption>Penguin Solutions (NASDAQ: PENG) has projected its FY2027 GAAP EPS to be between $2.80 and $4.20, significantly higher than the analyst estimate of $2.13. This indicates a positive outlook for the company&#39;s earnings in the upcoming fiscal year.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/PENG:1791317426052</loc>
    <lastmod>2026-10-06T20:10:26.052Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/PENG/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Penguin Solutions Sees FY2027 Adj EPS $3.75-$5.15 vs $3.25 Est; Sees Sales $2.182B-$2.666B vs $2.201B Est</image:title>
      <image:caption>Penguin Solutions (NASDAQ: PENG) has projected its FY2027 adjusted earnings per share (EPS) to be between $3.75 and $5.15, exceeding the analyst estimate of $3.25. The company also anticipates sales in the range of $2.182 billion to $2.666 billion, compared to the analyst estimate of $2.201 billion.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/ELVN:1791317392728</loc>
    <lastmod>2026-10-06T20:09:52.728Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/ELVN/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Enliven Therapeutics Announces FDA Alignment On Phase 3 Relcobatinib Chronic Myeloid Leukemia Trial Design, Expects Start Before Year-End</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/STZ:1791317373726</loc>
    <lastmod>2026-10-06T20:09:33.726Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/STZ/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Constellation Brands Raises FY2027 GAAP EPS Guidance from $11.50-$12.20 to $11.85-$12.55 vs $11.93 Est</image:title>
      <image:caption>Constellation Brands (NYSE: STZ) has raised its FY2027 GAAP EPS guidance from a range of $11.50-$12.20 to $11.85-$12.55, surpassing the analyst estimate of $11.93. This adjustment indicates a positive outlook for the company&#39;s earnings performance in the upcoming fiscal year.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/ZIM:1791317343033</loc>
    <lastmod>2026-10-06T20:09:03.033Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/ZIM/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>ZIM Raises FY2026 Adjusted EBITDA Guidance To $2.7B-$3B From $2B-$2.4B, Adjusted EBIT To $1.4B-$1.7B From $700M-$1.1B</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/STZ:1791317312935</loc>
    <lastmod>2026-10-06T20:08:32.935Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/STZ/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Constellation Brands Q2 Adj. EPS $3.74 Beats $3.56 Estimate, Sales $2.633B Beat $2.542B Estimate</image:title>
      <image:caption>Constellation Brands (NYSE: STZ) reported Q2 adjusted earnings per share of $3.74, exceeding the analyst estimate of $3.56 by 4.76%. This reflects a 3.03% increase compared to $3.63 per share from the same period last year. The company also reported quarterly sales of $2.633 billion, surpassing the $2.542 billion estimate by 3.58% and marking a 6.13% increase from $2.481 billion in the previous year.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/CRBU:1791317285531</loc>
    <lastmod>2026-10-06T20:08:05.531Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/CRBU/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Caribou Biosciences Announces Strategic Alternatives Review, Discontinues Vispa-Cel And CB-011 CAR-T Programs, Cuts Workforce; Had $113.8M Cash At June 30</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/CRBU:1791317278867</loc>
    <lastmod>2026-10-06T20:07:58.867Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/CRBU/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Caribou Biosciences Mulls Strategic Options To Maximize Shareholder Value; Intends To Discontinue Further Development Activities For Two Allogeneic CAR-T Cell Therapy Programs</image:title>
      <image:caption>Caribou Biosciences, Inc. (Nasdaq: CRBU) is exploring strategic alternatives to enhance shareholder value and will cease development of its two allogeneic CAR-T cell therapy programs, vispa-cel and CB-011. The company plans to implement workforce and cost reductions as part of this decision.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/HALO:1791317179954</loc>
    <lastmod>2026-10-06T20:06:19.954Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/HALO/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Halozyme Therapeutic Expands Collaboration, License Deal With Argenx Over Development, Commercialization Of ENHANCE With Two Additional Targets</image:title>
      <image:caption>Halozyme Therapeutics, Inc. (Nasdaq: HALO) has expanded its collaboration and license agreement with argenx to include the development and commercialization of ENHANZE® for two additional exclusive targets. This strategic move enhances their partnership and broadens the scope of their therapeutic developments.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/SAR:1791317179085</loc>
    <lastmod>2026-10-06T20:06:19.085Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/SAR/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Saratoga Investment Q2 Adj. EPS $0.45 Misses $0.49 Estimate, Sales $31.169M Miss $31.700M Estimate</image:title>
      <image:caption>Saratoga Investment (NYSE:SAR) reported Q2 adjusted earnings per share of $0.45, missing the analyst estimate of $0.49 by 8.16%, and down 22.41% from $0.58 in the same period last year. The company&#39;s quarterly sales were $31.169 million, falling short of the $31.700 million estimate by 1.68%, but representing a 1.77% increase from $30.626 million in the prior year.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/MAZE:1791317168876</loc>
    <lastmod>2026-10-06T20:06:08.876Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/MAZE/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Maze Therapeutics Announces Presentation Of Updated Phase 2 MZE829 Kidney Disease Data At ASN Kidney Week On October 24</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/PENG:1791317165108</loc>
    <lastmod>2026-10-06T20:06:05.108Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/PENG/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Penguin Solutions Q4 Adj. EPS $1.00 Beats $0.78 Estimate, Sales $566.685M Beat $516.115M Estimate</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/BBIO:1791316996220</loc>
    <lastmod>2026-10-06T20:03:16.220Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/BBIO/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>BridgeBio Announces Presentation Of Attruby Amyloid Heart Disease Data At HFSA October 9-12, Including Real-World Comparison vs. Tafamidis</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/BRTX:1791316993670</loc>
    <lastmod>2026-10-06T20:03:13.670Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/BRTX/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Maxim Group Downgrades BioRestorative Therapies to Hold</image:title>
      <image:caption>Maxim Group analyst Michael Okunewitch has downgraded BioRestorative Therapies (NASDAQ: BRTX) from a &#39;Buy&#39; rating to &#39;Hold&#39;. This change reflects a shift in the analyst&#39;s outlook on the company&#39;s stock performance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/NEOG:1791316945634</loc>
    <lastmod>2026-10-06T20:02:25.634Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/NEOG/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Neogen Raises FY2027 Sales Guidance from $880.000M-$885.000M to $885.000M-$890.000M vs $883.175M Est</image:title>
      <image:caption>Neogen (NASDAQ: NEOG) has raised its sales guidance for FY2027 from a range of $880 million-$885 million to $885 million-$890 million, surpassing the previous estimate of $883.175 million. This adjustment reflects a positive outlook for the company&#39;s financial performance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/NEOG:1791316903946</loc>
    <lastmod>2026-10-06T20:01:43.946Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/NEOG/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Neogen Q1 Adj. EPS $0.08 Beats $(0.07) Estimate, Sales $222.800M Beat $208.175M Estimate</image:title>
      <image:caption>Neogen (NASDAQ: NEOG) reported Q1 adjusted earnings per share of $0.08, surpassing the analyst estimate of $(0.07) by 214.29%, and reflecting a 100% increase from $0.04 per share in the same period last year. The company&#39;s quarterly sales reached $222.800 million, exceeding the $208.175 million estimate by 7.03%, and marking a 6.51% increase from $209.189 million in the prior year.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/RZLT:1791316887669</loc>
    <lastmod>2026-10-06T20:01:27.669Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/RZLT/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Lake Street Maintains Buy on Rezolute, Raises Price Target to $12</image:title>
      <image:caption>Lake Street analyst Daniel Brims has maintained a Buy rating on Rezolute (NASDAQ: RZLT) and raised the price target from $9 to $12. This adjustment reflects a positive outlook for the company in the market.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/TNON:1791316884574</loc>
    <lastmod>2026-10-06T20:01:24.574Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/TNON/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Tenon Medical Announces Notice Of Allowance For U.S. Patent Application Covering Sacroiliac Joint Stabilization Systems</image:title>
      <image:caption>Tenon Medical has received a Notice of Allowance for its U.S. patent application related to sacroiliac joint stabilization systems. This development may enhance the company&#39;s intellectual property portfolio and support its market position in orthopedic solutions. The stock ticker for Tenon Medical is TNON.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/NOK:1791316792555</loc>
    <lastmod>2026-10-06T19:59:52.555Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/NOK/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Nokia shares are trading higher after the company&amp;#39;s CEO Justin Hotard, said AI data center demand remains strong and AI customers would build centers twice as fast if possible, which may boost investor confidence in the communications equipment industry.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/COCH:1791316585032</loc>
    <lastmod>2026-10-06T19:56:25.032Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/COCH/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Lake Street Initiates Coverage On Envoy Medical with Buy Rating, Announces Price Target of $2.5</image:title>
      <image:caption>Lake Street analyst Frank Takkinen has initiated coverage on Envoy Medical (NASDAQ: COCH) with a Buy rating. The firm has set a price target of $2.50 for the stock.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/VCIG:1791316231620</loc>
    <lastmod>2026-10-06T19:50:31.620Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/VCIG/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>VCI Global Rolls Out VGAIN Compute AI Token Platform</image:title>
      <image:caption>VCI Global Limited (NASDAQ: VCIG) has launched the VGAIN Compute AI token platform through its subsidiary V Gallant Limited. This initiative represents a significant move for the company as it expands into AI infrastructure, GPU computing, and AI services.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/NVDA:1791315786871</loc>
    <lastmod>2026-10-06T19:43:06.871Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/NVDA/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Nvidia Announces Telecom Operators Building Their AI Strategies On Open Models; Open Models Offer Control, Tailored AI Throughout Most Critical Workloads</image:title>
      <image:caption>Nvidia has announced that telecom operators are increasingly adopting open models to develop their AI strategies, which provide greater control and customization for critical workloads. This shift towards open models indicates a trend in the telecom industry to enhance AI capabilities while maintaining flexibility. The initiative aligns with Nvidia&#39;s ongoing efforts to support AI advancements across various sectors, including telecommunications.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/COIN:1791315217468</loc>
    <lastmod>2026-10-06T19:33:37.468Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/06/Coinbase-Tops-Earnings-Estimates.jpg?width=250&amp;height=187</image:loc>
      <image:title>CFTC Approval &amp;#39;Opens Many Doors,&amp;#39; Top Coinbase Exec Says</image:title>
      <image:caption>Coinbase Global Inc. (NASDAQ: COIN) has received CFTC approval for its clearing house, completing its derivatives registrations and allowing the company to bring more operations in-house, which reduces reliance on third parties. Vice Chairman Ryan Van Grack stated that this regulatory change could accelerate crypto product innovation and expand institutional adoption of Bitcoin through clearer custody rules. He emphasized that tokenization could significantly reshape traditional markets by enabling global trading of various assets with improved transparency and efficiency.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/GOOG:1791314905814</loc>
    <lastmod>2026-10-06T19:28:25.814Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/GOOG/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>&amp;#39;Waymo Boosts Private Debt Deal to $5 Billion in Push for Growth&amp;#39; - Bloomberg</image:title>
      <image:caption>Waymo has increased its private debt deal to $5 billion as part of its strategy to accelerate growth. This move reflects the company&#39;s ongoing efforts to expand its operations in the autonomous vehicle sector. The funding is expected to support Waymo&#39;s initiatives and technological advancements in the industry.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/SAH:1791314845462</loc>
    <lastmod>2026-10-06T19:27:25.462Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/SAH/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>JP Morgan Maintains Underweight on Sonic Automotive, Lowers Price Target to $64</image:title>
      <image:caption>JP Morgan analyst Rajat Gupta has maintained an Underweight rating on Sonic Automotive (NYSE: SAH) and has lowered the price target from $72 to $64. This adjustment reflects a more cautious outlook on the company&#39;s performance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/PCVX:1791314339877</loc>
    <lastmod>2026-10-06T19:18:59.877Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/PCVX/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Vaxcyte shares are trading lower after the company announced a $500 million equity offering and $500 million Convertible Notes offering.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
</urlset>